期刊
BMC INFECTIOUS DISEASES
卷 10, 期 -, 页码 -出版社
BMC
DOI: 10.1186/1471-2334-10-356
关键词
-
资金
- Institut pour la Recherche et le Developpement
- Total
- Government of Gabon
- Total-Fina-Elf Gabon
- French Ministere des affaires Etrangeres et Europeennes, France
Background: Dengue is now a leading cause of morbidity and mortality throughout the tropics. We conducted the first ex vivo study of dengue fever (DF) in African patients infected during the first Gabonese dengue virus 2 (DENV-2) outbreak in 2007, in order to investigate cytokine production, including the antiviral cytokine IFN-alpha, reported to be a potent inhibitor of DENV replication in vitro. Methods: Levels of 50 cytokines, chemokines and growth factors were measured in plasma from 36 patients with DENV-2 infection, and in uninfected controls, using Luminex multiplex technology. The results were interpreted according to the day of sampling after symptom onset. PBMC from six patients were also studied for T lymphocyte cell surface marker expression by flow cytometry. Results: Acute DENV-2 infection elicited high levels of several pro-inflammatory cytokines (IL-6 and IL-17), chemokines (MIF, RANTES, IP-10 and MCP-1) and growth factors (G-CSF, GM-CSF and VEGF-A). We also observed high levels of IFN-a for the first time in adult DF patients, and CD4+ and CD8+ T cell activation at symptom onset. Conclusion: Acute DENV-2 infection in African patients elicits a strong innate response involving IFN-a production, as well as an adaptive immune response.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据